Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 903

Similar articles for PubMed (Select 19584380)

1.

Prefilter bivalirudin for preventing hemofilter occlusion in continuous renal replacement therapy.

Mueller SW, MacLaren R, Fish DN, Kiser TH.

Ann Pharmacother. 2009 Jul;43(7):1360-5. doi: 10.1345/aph.1M179. Epub 2009 Jul 7.

PMID:
19584380
3.

Coagulation, Fibrinolysis and Inhibitors in Failing Filters during Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: Effect of Anticoagulation Modalities.

Schilder L, Nurmohamed SA, Ter Wee PM, Paauw NJ, Girbes AR, Beishuizen A, Beelen RH, Groeneveld AB.

Blood Purif. 2015 May 6;39(4):297-305. [Epub ahead of print]

PMID:
25966765
4.
5.

Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery.

McNair E, Marcoux JA, Bally C, Gamble J, Thomson D.

Perfusion. 2015 May 1. pii: 0267659115583525. [Epub ahead of print] Review.

PMID:
25934498
6.

Early mobilization on continuous renal replacement therapy is safe and may improve filter life.

Jacobs FM.

Crit Care. 2015 Apr 28;19:205. doi: 10.1186/s13054-015-0781-4. No abstract available.

7.

Catheter-directed thrombolysis with alteplase and bivalirudin in a patient with heparin-induced thrombocytopenia.

Martinez LA, Burnett AE.

Am J Health Syst Pharm. 2015 May 1;72(9):707-10. doi: 10.2146/ajhp140474.

PMID:
25873618
8.

Reply: efficacy and safety of argatroban and bivalirudin in patients with suspected heparin-induced thrombocytopenia.

Vo QA, Lin JK, Tong LM.

Ann Pharmacother. 2015 Apr;49(4):500. doi: 10.1177/1060028015572440. No abstract available.

PMID:
25762658
9.

Comment: efficacy and safety of argatroban and bivalirudin in patients with suspected heparin-induced thrombocytopenia.

Miyares MA.

Ann Pharmacother. 2015 Apr;49(4):499. doi: 10.1177/1060028015571727. No abstract available.

PMID:
25762657
10.

Citrate for continuous renal replacement therapy: safer, better and cheaper.

Oudemans-van Straaten HM.

Crit Care. 2014 Dec 3;18(6):661. doi: 10.1186/s13054-014-0661-3.

11.

CASE 1--2015: left ventricular assist device insertion in a patient with heparin-induced thrombocytopenia and renal failure.

Nhieu S, Nguyen L, Pretorius V, Ovando J, Moore D, Banks D, Koster A, Morshuis M, Faraoni D.

J Cardiothorac Vasc Anesth. 2015 Feb;29(1):210-20. doi: 10.1053/j.jvca.2014.09.009. No abstract available.

PMID:
25620146
12.

Transfemoral Transcatheter Aortic Valve Replacement in a Patient With Heparin-Induced Thrombocytopenia: Intraoperative Anticoagulation Management With Bivalirudin (Angiomax).

Scott B, Tam CW, Moon RS.

J Cardiothorac Vasc Anesth. 2015 Jan 17. pii: S1053-0770(14)00526-6. doi: 10.1053/j.jvca.2014.10.018. [Epub ahead of print] No abstract available.

PMID:
25604599
13.

Anticoagulation with bivalirudin during deep hypothermic circulatory arrest in a patient with heparin-induced thrombocytopenia.

Pericleous A, Sadek M, Fitzmaurice M, Caldwell C, Natividad K, Plestis KA.

Tex Heart Inst J. 2014 Dec 1;41(6):645-8. doi: 10.14503/THIJ-13-3631. eCollection 2014 Dec.

14.

Anticoagulation strategies in venovenous hemodialysis in critically ill patients: a five-year evaluation in a surgical intensive care unit.

Sponholz C, Bayer O, Kabisch B, Wurm K, Ebert K, Bauer M, Kortgen A.

ScientificWorldJournal. 2014;2014:808320. doi: 10.1155/2014/808320. Epub 2014 Dec 9.

15.

Plasma exchange on venovenous extracorporeal membrane oxygenation with bivalirudin anticoagulation.

Preston TJ, Dalton HJ, Nicol KK, Ferrall BR, Miller JC, Hayes D Jr.

World J Pediatr Congenit Heart Surg. 2015 Jan;6(1):119-22. doi: 10.1177/2150135114553476.

PMID:
25548358
16.

Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.

Vo QA, Lin JK, Tong LM.

Ann Pharmacother. 2015 Feb;49(2):178-84. doi: 10.1177/1060028014562949. Epub 2014 Dec 16.

PMID:
25515865
17.

Clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy.

Cope J, Bushwitz J, An G, Antigua A, Patel A, Zumberg M.

Ann Pharmacother. 2015 Mar;49(3):270-7. doi: 10.1177/1060028014563325. Epub 2014 Dec 16.

PMID:
25515864
18.

Bivalirudin and transcatheter aortic valve replacement: a cautionary tale.

Sangani NK, Greason KL, Torres NE, Suri RM, Mathew V.

Ann Thorac Surg. 2014 Dec;98(6):2214-5. doi: 10.1016/j.athoracsur.2014.01.074. Epub 2014 Dec 1.

PMID:
25468094
19.

Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia.

Lehner GF, Schöpf M, Harler U, Pechlaner C, Joannidis M.

Blood Purif. 2014;38(2):127-30. doi: 10.1159/000366125. Epub 2014 Nov 20.

PMID:
25412655
20.

Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.

Treschan TA, Schaefer MS, Geib J, Bahlmann A, Brezina T, Werner P, Golla E, Greinacher A, Pannen B, Kindgen-Milles D, Kienbaum P, Beiderlinden M.

Crit Care. 2014 Oct 25;18(5):588. doi: 10.1186/s13054-014-0588-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk